BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
11/12/2024 12:23:43 PM | Browse: 46 | Download: 155
 |
Received |
|
2024-08-10 04:56 |
|
Peer-Review Started |
|
2024-08-10 04:56 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2024-09-24 12:38 |
|
Revised |
|
2024-09-25 17:19 |
|
Second Decision |
|
2024-10-18 01:29 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2024-10-18 08:44 |
|
Articles in Press |
|
2024-10-18 08:44 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2024-10-25 13:44 |
|
Publish the Manuscript Online |
|
2024-11-12 12:23 |
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Surgery |
| Manuscript Type |
Editorial |
| Article Title |
Critical considerations for the management of gastrointestinal mixed neuroendocrine non-neuroendocrine neoplasms and pure neuroendocrine carcinomas
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Efstathios T Pavlidis, Ioannis N Galanis and Theodoros E Pavlidis |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Theodoros E Pavlidis, PhD, The 2nd Department of Propaedeutic Surgery, Hippokration General Hospital, School of Medicine, Aristotle University of Thessaloniki, Konstantinoupoleos 49, Thessaloniki 54642, Greece. pavlidth@auth.gr |
| Key Words |
Neuroendocrine neoplasms; Gastrointestinal neuroendocrine neoplasms; Mixed gastrointestinal neuroendocrine neoplasms; Gastrointestinal neuroendocrine carcinomas; Neuroendocrine carcinoma; Neuroendocrine non-neuroendocrine neoplasms |
| Core Tip |
The rare but steadily increasing number of gastrointestinal mixed neuroendocrine non-neuroendocrine neoplasms and pure neuroendocrine carcinomas require more radical treatment than slow-growing neuroendocrine neoplasms do and they are related to poor prognosis. They constitute a complicated diagnostic and therapeutic challenge. The current management strategy begins with surgery and is followed by chemotherapy. New chemotherapeutics and novel biological agents for targeted therapy, along with immunotherapy broaden the range of therapeutic options, providing promising outcomes. Effective management should be individualized and multidisciplinary. |
| Publish Date |
2024-11-12 12:23 |
| Citation |
<p>Pavlidis ET, Galanis IN, Pavlidis TE. Critical considerations for the management of gastrointestinal mixed neuroendocrine non-neuroendocrine neoplasms and pure neuroendocrine carcinomas. <i>World J Gastrointest Oncol</i> 2024; 16(12): 4559-4564</p> |
| URL |
https://www.wjgnet.com/1948-5204/full/v16/i12/4559.htm |
| DOI |
https://dx.doi.org/10.4251/wjgo.v16.i12.4559 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
